China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

Equities research analysts at StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHI) in a research report issued on Saturday. The brokerage set a “hold” rating on the stock.

China Pharma Stock Performance

NYSE CPHI opened at $0.20 on Friday. China Pharma has a 52 week low of $0.17 and a 52 week high of $0.74. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22. The company has a 50-day moving average price of $0.23 and a 200-day moving average price of $0.24.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.